D2 | Abstract 09
Annual NUTRIM Symposium 18 November 2020
APPLIED SCIENCE
The detrimental course of acute intestinal ischemia: improving the diagnosis (TACTIC TRIAL).
A.A.M. Duivenvoorden1, M. Clarysse2, K. Geboers2, S. Vets2, M. Trzpis-Bremer6, A. Stam5, R. Geelkerken5, J.P.P.M. de Vries6, J.P.M. Derikx7,8, J.T. Blauw7, H.C.L.J. Buscher4, L.J. Ceulemans2, H.C. Dejong1,2,9 T. Lubbers2,9 K. Lenaerts1; on behalf of the Dutch Mesenteric Ischemia Study group
1 Department of Surgery, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands
2 Department of Surgery, Maastricht University Medical Center, Maastricht, the Netherlands
3 Department of Abdominal Transplantation Surgery, UZ Leuven, Leuven, Belgium
4 Department of Vascular Surgery, Gelre Ziekenhuis, Apeldoorn, The Netherlands
5 Department of Vascular Surgery, Medische Spectrum Twente, Enschede, The Netherlands
6 Department of Surgery, University Medical Centre Groningen, Groningen, The Netherlands
7 Department of Intensive Care Medicine, Amsterdam UMC (location AMC), Amsterdam, The Netherlands
8 Department of Vascular Surgery, Amsterdam UMC (location VUMC), Amsterdam, The Netherlands
9 GROW - School for Oncology and Developmental Biology, Maastricht UMC+, Maastricht, The Netherlands
NUTRIM | School of Nutrition and Translational Research in Metabolism
NUTRIM aims to contribute to health maintenance and personalised medicine by unraveling lifestyle and disease-induced derangements in metabolism and by developing targeted nutritional, exercise and drug interventions. This is facilitated by a state of the art research infrastructure and close interaction between scientists, clinicians, master and PhD students.
www.maastrichtuniversity.nl/nutrim